Eli Lilly beats first-quarter expectations, driven by prescriptions amid coronavirus pandemic
Sales rose 15%, with the company citing strong demand for key products such as Trulicity, Taltz and Emgality.
https://ift.tt/2Vtvfrk
Eli Lilly beats first-quarter expectations, driven by prescriptions amid coronavirus pandemic
Eli Lilly beats first-quarter expectations, driven by prescriptions amid coronavirus pandemic
Sales rose 15%, with the company citing strong demand for key products such as Trulicity, Taltz and Emgality.
https://ift.tt/2Vtvfrk
Subscribe to:
Post Comments
(
Atom
)
Post a Comment